Who are the Companion Animal Genetics Market Top Companies and What are Their Offerings?

Turn complex Companion Animal Genetics Market data into clear, confident decisions - Access the dashboard.
| Companies | Headquarters | Companion Animal Genetics Products |
| Zoetis Inc. | Parsippany, U.S. | Genoscoper and Basepaws |
| Mars Petcare | Vancouver, U.S. | Wisdom Panel |
| Embark Veterinary, Inc. | Boston, U.S. | Embark Dog DNA Test |
| Neogen Corporation | Lansing, U.S. | Paw Print Genetics and Igenity Canine |
| IDEXX Laboratories | Westbrook, U.S. | IDEXX Reference Labs |
| Orivet | St Kilda, Australia | GenoPet and Breed Identification DNA Test |
| BioPet Laboratories | Konxville, U.S. | PooPrints and Know Your Pet DNA |
| Animal Genetics, Inc | Tallahassee, U.S. | Color Panels and Canine Health |
| Genetrack Biolabs | Vancouver, Canada | Genetrack Canine DNA Testing |
| EasyDNA | Kent, UK | Dog Parentage Test and Dog Allergy Test |
Recent Developments in the Companion Animal Genetics Market
- In March 2026, a definitive acquisition agreement with a $160 million deal was announced between Zoetis and Neogen Corporation. With the agreement, Zoetis will acquire Neogen’s beef, dairy genomics, and its cutting-edge technologies, offering accurate, deeper insights, and scalable genetic testing for the companion and livestock industries.
- In August 2025, a collaboration between POP, Embark Veterinary, and Innovative Pet Lab announced the launch of a 90-day canine health study to offer personalized nutrition, behavior tracking, and biological data to support long-term vitality and immune health. This study will offer over $600 in free health tools, like Embark's DNA test, POP's science-backed supplement POP-Topper, and Innovative Pet Lab's gut biomarker test kits to the participants.
Companion Animal Genetics Market Value Chain Analysis
R&D
- The R&D of companion animal genetics focuses on utilizing next-generation sequencing and AI-powered biobanks for breed identification and predictive precision medicine.
- Key players: Embark Veterinary, Inc., Zoetis Inc., Mars Petcare.
Clinical Trials and Regulatory Approvals
- The clinical performance, analytical validity, and identification of disease-linked genetic markers are evaluated in the clinical trials and regulatory approvals of companion animal genetics.
- Key players: Zoetis Inc., Mars Petcare.
Formulation and Final Dosage Preparation
- The formulation and final dosage preparation of the companion animal genetics involves the development of next-generation sequencing or PCR platforms with the use of stabilizing buffers, reagents, and primers.
- Key players: Embark Veterinary, Inc., Zoetis Inc., Mars Petcare.
Packaging and Serialization
- The packaging and serialization of companion animal genetics involves the use of tamper-evident, barcoded medical-grade packaging and GS1-compliant tracking systems.
- Key players: Embark Veterinary, Inc., Zoetis Inc., Mars Petcare.
Distribution to Hospitals, Pharmacies
- The specialized veterinary wholesalers and national medical distributors are responsible for the distribution of companion animal genetics products to the hospitals and pharmacies.
- Key players: Zoetis Inc., IDEXX Laboratories.
Patient Support and Services
- Breeder tools, expert veterinary genetic counseling, and personalized wellness and nutrition strategies are provided in the patient support and services of the companion animal genetics.
- Key players: Embark Veterinary, Orivet, Mars Petcare.
Market Growth
The global companion animal genetics market size was estimated at USD 4.92 billion in 2025 and is predicted to increase from USD 5.4 billion in 2026 to approximately USD 12.59 billion by 2035, expanding at a CAGR of 9.85% from 2026 to 2035.

Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking